Oxford Malaria vaccine proves highly effective in Burkina Faso trial
Vaccine developed by scientists at Jenner Institute, Oxford, shows up to 77% efficacy in trial over 12 months. A mother in Burkin a Faso,...
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults
Summary Background Whether young adults who are infected with SARS-CoV-2 are at risk of subsequent infection is uncertain. We...
Surprising Nuggets From The WHO Report: Our Science Correspondent Digs In
When COVID-19 first broke out in Wuhan, scientists tracked a large number of the cases to the Huanan Seafood Market in Wuhan. Above: The...
April 2021 update to TIGER: The world economy stumbles toward a two-track recovery
Editor's Note: In collaboration with the Financial Times (FT), Eswar Prasad of Brookings and Aryan Khanna and Darren Chang of Cornell...
How the Sinopharm Vaccine Works
In early 2020, the Beijing Institute of Biological Products created an inactivated coronavirus vaccine called BBIBP-CorV. Clinical trials...